PARDES BIOSCIENCES INC's ticker is and the CUSIP is 69945Q105. A total of 60 filers reported holding PARDES BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $86,272 | – | 47,664 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Opportunity Management V, LLC | 5,227,307 | $9,671,000 | 29.04% |
| Foresite Capital Management V, LLC | 9,400,515 | $17,391,000 | 13.37% |
| Lynx1 Capital Management LP | 2,275,732 | $4,210,000 | 3.80% |
| VK Services, LLC | 6,151,766 | $11,381,000 | 1.70% |
| Arena Capital Advisors, LLC- CA | 851,281 | $1,575,000 | 0.48% |
| RA Capital Management | 6,175,038 | $11,424,000 | 0.24% |
| DAFNA Capital Management LLC | 479,386 | $887,000 | 0.24% |
| Chescapmanager LLC | 361,716 | $669,000 | 0.16% |
| Altai Capital Management | 82,097 | $152,000 | 0.15% |
| Frazier Life Sciences Management, L.P. | 845,636 | $1,564,000 | 0.12% |